Dr. Herati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
430 E 29th St
5th Floor Room 512
New York, NY 10016
Education & Training
- University of Pennsylvania Health SystemFellowship, Infectious Disease, 2011 - 2013
- Johns Hopkins University School of MedicineResidency, 2008 - 2011
- Washington University in St. Louis School of MedicineClass of 2008
Certifications & Licensure
- NY State Medical License 2019 - 2026
- PA State Medical License 2011 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Understanding Poor Vaccine Responses to Hepatitis B Vaccination Start of enrollment: 2022 Jul 07
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 2 citationsCombination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8T cells.Kevin Wang, Paulina Coutifaris, David Brocks, Guanning Wang, Tarek Azar
Cancer Cell. 2024-09-09 - 40 citationsPD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.Ramin Sedaghat Herati, David A Knorr, Laura A Vella, Luisa Victoria Silva, Lakshmi Chilukuri
Nature Immunology. 2022-08-01 - 26 citationsNeutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies.Takuya Tada, Hao Zhou, Marie I Samanovic, Belinda M Dcosta, Amber Cornelius
Frontiers in Immunology. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: